Drugs Imported
-
{
- All
- News
- Videos
-
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with trade-offs.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Detox Trends vs Real Liver Care: Doctor Explains What Actually Works
A balanced lifestyle plays the biggest role in keeping your liver healthy. This includes eating a nutrient-rich diet, staying hydrated, and maintaining regular physical activity
-
Scientists Find Reversible Male Birth Control That Stops Sperm Production
A new study brings scientists closer to a safe, reversible male birth control pill. Researchers found a way to temporarily stop sperm production without lasting harm, raising hope for more contraceptive options for men.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
What Happens If You Stop Taking Antibiotics In The Middle Of A Course?
It is important that you complete the full course of your antibiotics as it reduces side effects like nausea or allergic reactions and chances of reinfection. However, a lot of people don't adhere to your medications, which can impact your health.
-
Are Young Indians Misinformed About Contraception? Doctor Warns About The Growing Impact Of Social Media Myths
Reliance on inadequate awareness and peer advice contributes to rising unprotected encounters.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
Union Budget 2026: How Import Duty Exemption On Rare Disease Drugs Could Make Treatments Cheaper
The Union Budget 2026-27 includes customs duty exemptions on drugs and medical foods used to treat seven rare diseases under India's National Policy for Rare Diseases, potentially lowering costs for patients reliant on imported therapies.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
India Sets Import Price Floor On Key Penicillin Ingredients To Protect Drug Supply
The government has imposed a minimum import price on three key penicillin ingredients for one year, aiming to support domestic manufacturers and secure India's antibiotic supply chain.
-
Historic India-EU Trade Deal Could Impact Prices Of Weight Loss And Lifesaving Drugs, Here's How
India's landmark free trade deal with the European Union may lower import costs for some medicines, including weight-loss and lifesaving drugs. But experts say patient prices will depend on patents, regulation, and how benefits pass through the suppl
-
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with trade-offs.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Detox Trends vs Real Liver Care: Doctor Explains What Actually Works
A balanced lifestyle plays the biggest role in keeping your liver healthy. This includes eating a nutrient-rich diet, staying hydrated, and maintaining regular physical activity
-
Scientists Find Reversible Male Birth Control That Stops Sperm Production
A new study brings scientists closer to a safe, reversible male birth control pill. Researchers found a way to temporarily stop sperm production without lasting harm, raising hope for more contraceptive options for men.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
What Happens If You Stop Taking Antibiotics In The Middle Of A Course?
It is important that you complete the full course of your antibiotics as it reduces side effects like nausea or allergic reactions and chances of reinfection. However, a lot of people don't adhere to your medications, which can impact your health.
-
Are Young Indians Misinformed About Contraception? Doctor Warns About The Growing Impact Of Social Media Myths
Reliance on inadequate awareness and peer advice contributes to rising unprotected encounters.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
Union Budget 2026: How Import Duty Exemption On Rare Disease Drugs Could Make Treatments Cheaper
The Union Budget 2026-27 includes customs duty exemptions on drugs and medical foods used to treat seven rare diseases under India's National Policy for Rare Diseases, potentially lowering costs for patients reliant on imported therapies.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
India Sets Import Price Floor On Key Penicillin Ingredients To Protect Drug Supply
The government has imposed a minimum import price on three key penicillin ingredients for one year, aiming to support domestic manufacturers and secure India's antibiotic supply chain.
-
Historic India-EU Trade Deal Could Impact Prices Of Weight Loss And Lifesaving Drugs, Here's How
India's landmark free trade deal with the European Union may lower import costs for some medicines, including weight-loss and lifesaving drugs. But experts say patient prices will depend on patents, regulation, and how benefits pass through the suppl
